Literature DB >> 27477594

Long-Term Use and Safety of Migraine Preventive Medications.

Juliana VanderPluym1, Randolph W Evans2, Amaal J Starling3.   

Abstract

Migraine preventive medications are used to reduce the frequency, severity, and disability of migraine attacks. Once migraine preventive therapy is initiated, the question of how long to maintain this therapy arises. This article will explore the literature pertaining to the long-term use of migraine preventive medications, including length of treatment and safety with long-term exposure.
© 2016 American Headache Society.

Entities:  

Keywords:  anticonvulsants; antidepressants; beta blockers; headache; migraine; preventive therapy

Mesh:

Substances:

Year:  2016        PMID: 27477594     DOI: 10.1111/head.12891

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

Review 1.  Nutraceuticals and Behavioral Therapy for Headache.

Authors:  Rebecca Barmherzig; Thilinie Rajapakse
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

2.  [Pain and epilepsy : A clinical, neuroanatomical and pathophysiological review].

Authors:  P Martin
Journal:  Schmerz       Date:  2018-08       Impact factor: 1.107

3.  Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.

Authors:  Janet H Ford; Shonda A Foster; Virginia L Stauffer; Dustin D Ruff; Sheena K Aurora; Jan Versijpt
Journal:  Patient Prefer Adherence       Date:  2018-11-13       Impact factor: 2.711

4.  Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.

Authors:  Virginia L Stauffer; Ryan Sides; Michel Lanteri-Minet; William Kielbasa; Yan Jin; Katherine J Selzler; Stewart J Tepper
Journal:  Patient Prefer Adherence       Date:  2018-09-17       Impact factor: 2.711

5.  A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.

Authors:  Angelo Camporeale; David Kudrow; Ryan Sides; Shufang Wang; Annelies Van Dycke; Katherine J Selzler; Virginia L Stauffer
Journal:  BMC Neurol       Date:  2018-11-09       Impact factor: 2.474

6.  L-carnitine versus Propranolol for pediatric migraine prophylaxis.

Authors:  Laya Amini; Omid Yaghini; Mohammadreza Ghazavi; Nahid Aslani
Journal:  Iran J Child Neurol       Date:  2021-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.